McCune-Albright Syndrome
Also known as: McCune Albright Syndrome / Polyostotic fibrous dysplasia / McCune Albright syndrome (disorder) / Albright's disease / Polyostotic fibrous dysplasia of bone (disorder) / Albright Syndrome / Polyostotic fibrous dysplasia of bone / Fibrous Dysplasia, Polyostotic
Drug | Drug Name | Drug Description |
---|---|---|
DB00675 | Tamoxifen | A selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer, reduce the risk of invasive breast cancer following surgery, or reduce the risk of breast cancer in high risk women. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01006 | Letrozole | 1 | Completed | 1 |
DB01217 | Anastrozole | 2 | Completed | 1 |
DB00947 | Fulvestrant | 2 | Completed | 1 |
DB00082 | Pegvisomant | 3 | Completed | 1 |
DB06643 | Denosumab | 4 | Recruiting | 1 |